This is a 6-month, 100% remote study that will collect a broad range of data that may provide insight into the COVID-19 global pandemic. Data collected will include participant medical histories, history of prior SARS-CoV-2 infection and exposure to known cases. On an ongoing basis data will be collected on new contacts with known cases, the presence of COVID-19 symptoms, including severity and outcome, and information on the immune system response to SARS-CoV-2 infection.
This is a 6-month, 100% remote study that will collect a broad range of data that may provide
insight into the COVID-19 global pandemic. All data will be collected by participant entry
into a mobile app designed for this study.
Upon entering the study, participants will be asked a series of questions about their prior
exposure to the SARS-CoV-2 virus including reporting prior test results, and identification
and description of contact with known or cases or other high risk encounters. Participants
will also provide a detailed medical history.
On on ongoing basis, participants will be asked to report any symptoms associated with
COVID-19 that they develop, and any new contacts they experience with known cases. Some
participants will be sent an at-home SARS-CoV-2 antibody test and asked to report the
results. In addition, participants will be asked to report the result of any other test they
receive for COVID-19 outside of the study.
Inclusion Criteria:
- Open to any adult individuals (18 years of age or older) permanently residing in the
United States
- Have regular access to smartphone and internet sufficient to support registry demands
- Willing and able to follow the procedures of the study
- Willing and able to provide informed consent
Exclusion Criteria:
- Participants unable to understand the study protocol or provide informed consent
- Participants unable or unwilling to perform all requested study tasks
ObvioHealth
Orlando, Florida, United States